New Russian cancer drug increases survival rate of mice by over 50%

09:14 06/06/2018
A group of researchers from the National University of Science and Technology MISIS (NUST MISIS) and the Pirogov Russian National Research Medical University have conducted preclinical studies of a new cancer drug based on magnetic nanoparticles.
Leave your comment